Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications.

Dormuth, Colin R; Kim, Jason D; Fisher, Anat; Piszczek, Jolanta; Kuo, I Fan

Dormuth, Colin R; Kim, Jason D; Fisher, Anat; Piszczek, Jolanta; Kuo, I Fan.

Afiliação

Dormuth CR; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Kim JD; Therapeutics Initiative, University of British Columbia, Vancouver, British Columbia, Canada.
Fisher A; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Piszczek J; Therapeutics Initiative, University of British Columbia, Vancouver, British Columbia, Canada.
Kuo IF; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.

JAMA Netw Open ; 6(10): e2336678, 2023 10 02.

Article em En | MEDLINE | ID: mdl-37782496

Assuntos

COVID-19; Ritonavir; Adulto; Humanos; Feminino; Masculino; Ritonavir/uso terapêutico; Tratamento Farmacológico da COVID-19; Vacinas contra COVID-19; Estudos de Coortes; Hospitalização; Colúmbia Britânica/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Ritonavir / COVID-19 Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: America do norte Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google